InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,196.83
(
0.31%
)
US TECH 100
17,657.99
(
0.27%
)
Dow Jones
38,922.54
(
0.18%
)
Brent Oil
83.57
(
0.11%
)
Bitcoin
63,497.99
(
0.52%
)
Post# of 30352
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next

sci101

Send PM Follow Ignore
Followers 2
Posts 125
Boards Moderated 0
Alias Born 06/30/2014

sci101

Re: saorsa post# 23381

Thursday, 09/17/2015 7:53:49 AM

Thursday, September 17, 2015 7:53:49 AM

Post# of 30352
Results are nearly perfect for this type of small study and exactly as I expected. This type of studies are designed for 2 reasons
1. safety
2. determine optimal dosing regime/protocol for the next trial
Showing some efficacy is a big bonus at this stage and it seems to me that we have it.
Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent SEEL News
More SEEL News
InvestorsHub NewsWire

FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM

Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Start posting your company's news
Only $200 per official company press release!